- Home
- Products
- Customized FluoroAb™
- EFNA4
- Anti-EFNA4 MAb (Clone 1)-iFluor® 555 Succinimidyl Ester
Anti-EFNA4 MAb (Clone 1)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS15614)
- TARGET
- ANTIBODY
- DYE
- Name
- EFNA4
- Overview
- Anti-EFNA4-antibody (Clone 1)
- Species Reactivity
- Human
- Name
- iFluor® 555 Succinimidyl Ester
- Color
- Yellow
- Excitation⁄Emission (nm)
- 557/570
- Detection method
- Fluorescent
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for WJY0-LS15614. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-019 | Anti-EFNA4-AcBut-CM ADC-2 | AcBut [-(4' acetyl phenoxy) butanoic acid] | CM (N-acetyl-y-calicheamicin dimethyl hydrazide) |
| ADC-W-018 | Anti-EFNA4-AcBut-CM ADC-1 | AcBut [-(4' acetyl phenoxy) butanoic acid] | CM (N-acetyl-y-calicheamicin dimethyl hydrazide) |
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-DLL3 MAb (Clone 7)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS493)
- Anti-SLITRK6 MAb (Clone 3)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS11777)
- Anti-TNFRSF10B MAb (Clone 8)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS10203)
- Anti-ERBB2 MAb (Clone 33)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS2443)
- Anti-STEAP1 MAb (Clone 1)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS444)
- Anti-Rabies Virus Glycoprotein MAb (Clone 6)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS10786)
- Anti-STEAP1 MAb (Clone 1)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS14286)
- Anti-HBV surface antigen MAb (Clone 3)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS10789)
- Anti-C-kit MAb (Clone 9)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8174)
- Anti-IGHE MAb (Clone 8)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS13604)
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.